MENU
+Compare
MRNS
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$0.24
Change
-$0.00 (-0.00%)
Capitalization
13.19M

MRNS Marinus Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of innovative neuropsychiatric therapeutics

Industry Biotechnology
MRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for MRNS with price predictions
Dec 20, 2024

Momentum Indicator for MRNS turns negative, indicating new downward trend

MRNS saw its Momentum Indicator move below the 0 level on December 04, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned negative. In of the 87 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRNS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MRNS entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for MRNS just turned positive on November 13, 2024. Looking at past instances where MRNS's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRNS advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

MRNS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.357) is normal, around the industry mean (14.529). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). MRNS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.416) is also within normal values, averaging (255.281).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MRNS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MRNS is expected to report earnings to fall 30.48% to -29 cents per share on March 11

Marinus Pharmaceuticals MRNS Stock Earnings Reports
Q4'24
Est.
$-0.29
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.04
Q1'24
Missed
by $0.03
Q4'23
Missed
by $0.12
The last earnings report on November 12 showed earnings per share of -41 cents, missing the estimate of -40 cents. With 1.14M shares outstanding, the current market capitalization sits at 13.19M.
A.I. Advisor
published General Information

General Information

a developer of innovative neuropsychiatric therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Matsonford Road
Phone
+1 484 801-4670
Employees
165
Web
https://www.marinuspharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QIPT2.490.08
+3.32%
Quipt Home Medical Corp
WEAV16.120.51
+3.27%
Weave Communications
CG50.221.19
+2.43%
Carlyle Group (The)
DBRG11.05-0.11
-0.99%
DigitalBridge Group
WATT0.29N/A
-1.69%
Energous Corp

MRNS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRNS has been loosely correlated with AXON. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MRNS jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRNS
1D Price
Change %
MRNS100%
-3.56%
AXON - MRNS
40%
Loosely correlated
+2.60%
NTLA - MRNS
39%
Loosely correlated
+0.83%
FOLD - MRNS
36%
Loosely correlated
+0.72%
AMRN - MRNS
35%
Loosely correlated
-1.18%
SAGE - MRNS
33%
Poorly correlated
+12.20%
More